Natalia M. Zaikova

Natalia M. Zaikova

Auto-generated profile, based on publicly available information

Natalia M. Zaikova

Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation; Veltischev Research and Clinical Institute for Pediatrics and Pediatric Surgery of the Pirogov Russian National Research Medical University

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 January 2021 in Journal Of Nephrology
Verified
Journal Article
Closed access
PDF file
MAMarina Aksenova
Marina Aksenova
NZNatalia Zaikova
Natalia Zaikova
TLTatiana Lepaeva
Tatiana Lepaeva

27 April 2023 in Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)
Verified
Journal Article
Closed access
PDF file
NZN. M. Zaikova
N. M. Zaikova
SMS. L. Morozov
S. L. Morozov
SRS. E. Ryabova
S. E. Ryabova
VDV. V. Dlin
V. V. Dlin
Barakat Syndrome (MIM#146255) is a rare autosomal dominant disease caused by GATA3 gene mutation and manifested by hypoparathyroidism (H), sensorineural deafness (D), and renal disease (R). HDR syndrome characterized by high clinical variability and prognosis. The exact prevalence of this disease is unknown, 180 cases are reported in the literature. Two clinical cases are presented. De novo heterozygous mutation in the GATA3 gene was detected in both patients. Our observations demonstrate variability of clinical phenotypes and poor prognosis in patients with Barakat Syndrome. The syndrome should be suspected in cases of early high-grade deafness and kidney disease presentation for the purpose of early diagnosis and appropriate therapy including the prevention of CKD progression.

2 August 2023 in Journal Of Nephrology
Verified
Journal Article
Closed access
PDF file
MAMarina Aksenova
Marina Aksenova
NZNatalia Zaikova
Natalia Zaikova
ETElena Tozliyan
Elena Tozliyan

28 August 2025 in Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)
Verified
Journal Article
Closed access
PDF file
MSM. P. Safonova
M. P. Safonova
OSO. A. Serebryakova
O. A. Serebryakova
ERE. A. Rubtsova
E. A. Rubtsova
NZN. M. Zaikova
N. M. Zaikova
АПА. Н. Подгорный
А. Н. Подгорный
EPE. A. Potrokhova
E. A. Potrokhova
ROHHAD is a poorly studied syndrome characterized by multisystem organ involvement and a high mortality rate. According to the literature, approximately 200 cases of this syndrome are known. ROHHAD syndrome has a presumably autoimmune mechanism of disease development, manifested by rapidly developing morbid obesity, hypothalamic dysfunction, apnea, and impaired autonomic regulation. The wide clinical variability of the syndrome complicates timely diagnosis. This article presents a clinical case of a 6-year-old girl with a rare ROHHAD syndrome and to demonstrate a set of the main clinical symptoms and diagnostic signs of the syndrome, as well as possible therapeutic approaches in the management of this life-threatening disease.

26 January 2026 in Nephrology (Saint-Petersburg)
Verified
Journal Article
Closed access
NZN. M. Zaikova
N. M. Zaikova
DMD. D. Magomedova
D. D. Magomedova
AHA. R. Hazhieva
A. R. Hazhieva
Familial hypomagnesemia with hypercalciuria and nephrocalcinosis (FHHNC) is a rare autosomal recessive disorder of the renal tubules caused by mutations in the CLDN 16 or CLDN19 genes encoding the proteins claudin-16 and claudin-19. CLDN 16 or CLDN19 play an important role in the cellular transport of magnesium and calcium in the thick ascending limb of the loop of Henle and are responsible for most of the tubular magnesium reabsorption. FHHNC is characterized by hypomagnesemia, hypercalciuria, medullary nephrocalcinosis, and eye involvement, and progresses to chronic renal failure requiring dialysis and kidney transplantation, mainly in young adults. A clinical case of rapidly progressive renal function decline in a patient with mutations in the CLDN19 gene without ocular involvement is demonstrated.

31 March 2021 in Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)
Verified
Journal Article
Open access
PDF file
MAM. E. Aksenova
M. E. Aksenova
NZN. M. Zaikova
N. M. Zaikova
TLT. V. Lepaeva
T. V. Lepaeva
VDV. V. Dlin
V. V. Dlin
Donnai–Barrow syndrome is a multi-system disorder characterized by a variable combination of congenital anomalies, progressive myopia, sensorineural hearing loss, intellectual disability and renal disease. The article describes clinical cases of children with different phenotypes of the syndrome, including different renal disorders. One patient had isolated low-molecular-weight proteinuria, another patient suffered from proteinuria, hypercalciuria, nephrocalcinosis. Disruption of megaline-mediated endocytosis, retrograde endosomal transport of ligands, mitochondrial dysfunction, stress of the endoplasmic reticulum can lead to a different spectrum and various degrees of severity of tubular dysfunction in Donnai-Barrow syndrome. A variety of clinical manifestations of the disease can lead to a low diagnosis of Donnai-Barrow syndrome and inadequate patient management.